• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 16-20, 2009

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Frank Torti, Acting Commissioner2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Randall Lutter, Deputy Commissioner for Policy2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine2/16/09 through 2/20/09N/AN/AN/ANo significant meetings
William Slikker, Director, National Center for Toxicological Research2/18-19/09Jefferson, ARNCTR staff & representatives from all other FDA Centers & ORACynthia Afshari (Amgen, Inc.), James A. Popp (Stratoxon LLC), Richard Judson (EPA), David Wishart (University of Alberta Canada), Walter Hill (Consultant), Richard S. Paules (NIEHS)Review of the research programs in NCTR's Division of Systems Toxicology
Jeffrey M. Senger, Acting Chief Counsel2/16/09 through 2/20/09N/AN/AN/ANo significant meetings